REVELES
CLINICAL TRIAL
SUPPORT & SERVICES
Reveles Clinical Services is a purposeful, technology-enabled clinical research solutions company. Reveles’ mission is Bringing Hope Closer To Home ™. Our vision is to become the preeminent provider and collaborator of clinical research solutions that accelerates the clinical development process and provides hope to patients with rare/complex diseases.
WHY
REVELES
Reveles has a commitment to expanding the population of people who are able to participate in clinical trials by removing the barriers that have long existed — particularly for minorities and underserved communities. We believe this important work will benefit patients, industry sponsors, and clinical researchers alike.
01
02
03
Increasing Awareness
In working to reach ethnic minorities and underserved communities, Reveles is helping to expand knowledge of clinical trials to a broader, more diverse population.
Expanded Access
By providing researchers and prospective trial participants with more ways to connect, Reveles is bringing hope to more patients and families. Sponsors in turn gain access to a more diverse population that could bring greater validity to their trial results.
Fostering Trust
By leveraging relationships with organizations that engage with ethnic minorities and the underserved, Reveles is working to foster trust and engagement in communities that are largely new to clinical research.
70%
70% of potential participants live more than 2 hours away from their nearest study center which limits recruitment and retention. (1)
80%
Out of 40,000 clinical trials recruiting in the US, 80% were delayed due to recruitment challenges. (2)
85%
85% of clinical trials fail to retain enough patients. (3)
30%
Across all clinical trials the average drop-out rate is 30%, when more than 12,000 people. (4)
75%
More than 75% responded that collecting all data on their own at home or having nurses come to their home for all study visits were appealing choices (3)
WHY DCT
(DECENTRALIZED CLINICAL TRIALS)
DCT
ADVANCING DIVERSITY
Reveles is expanding access to clinical research by combining local healthcare providers and digital health technologies. DCT's functions accelerate the drug development process through enhanced recruitment and retention, which result in faster completion times, increasing the speed of delivery of therapies to patients and creating efficiencies across clinical research processes.
DCT ADVANTAGES
Sites that have conducted at least one DCT reported multiple benefits, including decreased workload and less time spent on administrative tasks. Patients expressed more interest in clinical trials due to less travel and increased flexibility, and having access to study data anywhere at any time.
Faster Trial
Recruitment
Improved Trial Participant Retention
Home Administration and Direct-to-Patient Supply
Increased Participant Diversity
Improved Data Quality
Improved Patient Experience
PARTNERING TOGETHER
TO BRING HOPE CLOSER TO HOME
™
Whether a Site, CRO or Sponsor, Reveles is more than prepared to be your collaborative partner within the clinical research ecosystem. Let's work together to start Bringing Hope Closer to Home ™.
Reveles Clinical Services uses a tech enabled platform to support our DCT solutions which gives clients a viewpoint on progress and performance.
*available US domestically only
WE HAVE A FULLY DEDICATED DCT FACILITY
Our success depends on the highly-specialized, multi-disciplinary team with deep industry expertise discovering new drugs and innovating for the next generation. A fully-dedicated DCT facility and culture ensure they have a platform to do their best work.
CURRENT STRATEGIC PARTNERSHIPS
